Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
It was reported recently that human fibroblasts can be reprogrammed into a pluripotent state that resembles that of human embryonic stem (hES) cells. This was achieved by ectopic expression of four genes followed by culture on mouse embryonic fibroblast (MEF) feeders under a condition favoring hES cell growth. However, the efficiency of generating human induced pluripotent stem (iPS) cells is low, especially for postnatal human fibroblasts. We started supplementing with an additional gene or bioactive molecules to increase the efficiency of generating iPS cells from human adult as well as fetal fibroblasts. We report here that adding SV40 large T antigen (T) to either set of the four reprogramming genes previously used enhanced the efficiency by 23–70-fold from both human adult and fetal fibroblasts. Discernible hES-like colonies also emerged 1–2 weeks earlier if T was added. With the improved efficiency, we succeeded in replacing MEFs with immortalized human feeder cells that we previously established for optimal hES cell growth. We further characterized individually picked hES-like colonies after expansion (up to 24 passages). The majority of them expressed various undifferentiated hES markers. Some but not all the hES-like clones can be induced to differentiate into the derivatives of the three embryonic germ layers in both teratoma formation and embryoid body (EB) formation assays. These pluripotent clones also differentiated into trophoblasts after EB formation or bone morphogenetic protein 4 induction as classic hES cells. Using this improved approach, we also generated hES-like cells from homozygous fibroblasts containing the sickle cell anemia mutation Hemoglobin Sickle. Disclosure of potential conflicts of interest is found at the end of this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More studies are working on enhancing the iPSC reprogramming efficiency, such as by adding SV40 large T antigen (T) by 23–70-fold from human fibroblasts [104].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [104]
In the citing paper
“Suppression of p53 by viral protein or siRNA facilitated reprograming of iPS [70, 71].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [71]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Generation of human induced pluripotent stem cells from dermal fibroblasts
Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D., Tchieu, J., Sridharan, R., Clark, A. T., & Plath, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711983105 · Cited by 1,041
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
c-Myc Is Dispensable for Direct Reprogramming of Mouse Fibroblasts
Wernig, M., Meissner, A., Cassady, J. P., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.12.001 · Cited by 628
Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation
Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., & Weinberg, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2111-2123.2002 · Cited by 612
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation
Ahuja, D., Sáenz-Robles, M. T., & Pipas, J. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209046 · Cited by 557
Cited by
Items 101–200 of 291
Transient in vitro epigenetic reprogramming of skin fibroblasts into multipotent cells
Zhu, X., Pan, X.-H., Wang, W., Chen, Q., Pang, R., Cai, X., Hoffman, A. R., & Hu, J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.027 · Cited by 36
“Finally, the efficiency of forming iPS cells is still very low [16,18,22], probably reflecting the poor transduction of four viral vectors simultaneously into a single cell to achieve cell reprogramming.”
Han, Z., Zhong, L., Maina, N., Hu, Z., Li, X., Chouthai, N. S., Bischof, D., Weigel-Van Aken, K. A., Slayton, W. B., Yoder, M. C., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.161 · Cited by 35
Advancing stem cell technologies for conservation of wildlife biodiversity
Hutchinson, A. M., Appeltant, R., Burdon, T., Bao, Q., Bargaje, R., Bodnar, A. G., Chambers, S., Comizzoli, P., Cook, L., Endo, Y., et al. (2024) · Development · doi:10.1242/dev.203116 · Cited by 41
Culture Conditions and Enzymatic Passaging of Bovine ESC-Like Cells
Gong, G., Roach, M. L., Jiang, L., Yang, X., & Tian, X. (2010) · Cellular Reprogramming · doi:10.1089/cell.2009.0049 · Cited by 34
“Homologous fetal fibroblasts have been successfully used as feeder cells to derive ESCs in the mink (Sukoyan et al., 1993), pig (Li et al., 2004), and humans (Mali et al., 2008).”
Mouse induced pluripotent stem cells
Geoghegan, E., & Byrnes, L. (2008) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082640eg · Cited by 36
“In 2006, Yamanaka and co-workers surprised the scientific community when they reported that both mouse embryonic fibroblasts and tail tip fibroblasts could be reprogrammed to a pluripotent state similar to that observed in embryonic stem (ES) cells, by retroviral transduction of just four genes…”
BackgroundThe prospect of induced pluripotent stem cells for diabetes mellitus treatment
Soejitno, A., & Prayudi, P. K. A. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811420198 · Cited by 39
“2010] applied a long-term expansion of human iPS cells in a specific culture medium and successfully increased the iPS cell numbers up to sixfold, whereas Mali and colleagues [Mali et al. 2008] inserted SV40 large T antigen to one of the four delivered transcription factors and subsequently achieved a 23- to 70-fold i…”
BackgroundMethodInduced Pluripotent Reprogramming from Promiscuous Human Stemness‐Related Factors
Nelson, T. J., Martinez‐Fernandez, A., Yamada, S., Mael, A. A., Terzic, A., & Ikeda, Y. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00091.x · Cited by 33
Li, W., Chen, S., & Li, J. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.009 · Cited by 38
Chen, X. X., Zhai, Y., Yu, D., Cui, J., Hu, J., & Li, W. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25270 · Cited by 35
“On the other hand, supplementing the reprogramming cocktail with cell immortalization factors, like SV40 large T antigen and hTERT, enhances the efficiency of generating human iPSCs (Mali et al., 2008; Park et al., 2008).”
BackgroundStem cell biology and cell transplantation therapy in the retina
Osakada, F., Hirami, Y., & Takahashi, M. (2009) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-26-297 · Cited by 31
“Early reports used retroviral, lentiviral, and adenoviral vectors (Takahashi and Yamanaka, 2006; Brambrink et al., 2008; Mali et al., 2008; Stadtfeld et al., 2008b), but plasmids were also subsequently shown to be effective (Okita et al., 2008).”
BackgroundModeling blood diseases with human induced pluripotent stem cells
Georgomanoli, M., & Papapetrou, E. P. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039321 · Cited by 36
“, 2011a), viral oncoproteins such as SV40T and the catalytic subunit of the human telomerase (hTERT) (Park et al., 2008b; Mali et al., 2008),”
BackgroundZou, C., Chou, B.-K., Dowey, S. N., Tsang, K., Huang, X., Liu, C. F., Smith, C. J., Yen, J. S., Mali, P., Zhang, Y. A., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0688 · Cited by 33
“After 6 passages, pluripotency markers analysis, embryoid body (EB) differentiation, and teratoma formation were performed as previously described [22–25].”
Self-citationMethods for iPS cell generation for basic research and clinical applications
Mochiduki, Y., & Okita, K. (2012) · Biotechnology Journal · doi:10.1002/biot.201100356 · Cited by 33
Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders
Kusuma, S., & Gerecht, S. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.121 · Cited by 32
Higuchi, T., Kawagoe, S., Otsu, M., Shimada, Y., Kobayashi, H., Hirayama, R., Eto, K., Ida, H., Ohashi, T., Nakauchi, H., et al. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.02.012 · Cited by 29
Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating
Balvan, J., Gumulec, J., Raudenská, M., Křížová, A., Štěpka, P., Babula, P., Kizek, R., Adam, V., & Masařík, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145016 · Cited by 30
Stefano, B. D., Prigione, A., & Broccoli, V. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0180 · Cited by 31
Das, A. K., & Pal, R. (2010) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.258 · Cited by 34
“…successful generation of various differentiated cell types, including neurons (Chambers et al., 2009), haematopoietic and endothelial cells (Choi et al., 2009), pancreatic insulin-producing cells (Zhang et al., 2009), hepatocytelike cells (Song et al., 2009) and retinal cells (Meyer et al., 2009).”
BackgroundEfficient and rapid generation of induced pluripotent stem cells using an alternative culture medium
Zhao, X., Li, W., Lv, Z., Liu, L., Tong, M., Hai, T., Hao, J., Guo, C., Wang, X., Wang, L., et al. (2010) · Cell Research · doi:10.1038/cr.2010.26 · Cited by 30
Efficient induction and sustenance of pluripotent stem cells from bovine somatic cells
Pillai, V. V., Koganti, P. P., Kei, T. G., Gurung, S., Butler, W. R., & Selvaraj, V. (2021) · Biology Open · doi:10.1242/bio.058756 · Cited by 29
Ontological and Ethical Implications of Direct Nuclear Reprogramming
Magill, G., & Neaves, W. B. (2009) · Kennedy Institute of Ethics journal · doi:10.1353/ken.0.0276 · Cited by 29
“2002) or human iPS cells (Mali et al. 2008) with a specific cell signaling factor, bone morphogenetic protein 4.”
BackgroundDifferentiation of retinal ganglion cells from induced pluripotent stem cells: a review
Ji, S., & Tang, S. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2019.01.22 · Cited by 33
Dai, X., Liu, P., Lau, A. W., Liu, Y., & Inuzuka, H. (2014) · Cancer Medicine · doi:10.1002/cam4.298 · Cited by 29
“Although multiple methods have been attempted to enhance the iPS process, such as adding SV40 large T antigen [13], co-overexpressing MyoD [14], enhancing RA signaling [15], or depleting Mdb3 that is a core component of the NuRD complex [16], it remains largely unknown how the iPS process is regulated by upstream sign…”
MethodHypoxia Induces Pluripotency in Primordial Germ Cells by HIF1α Stabilization and Oct4 Deregulation
López-Iglesias, P., Alcaina, Y., Tàpia, N., Sabour, D., Araúzo-Bravo, M. J., de la Maza, D. S., Berra, E., Núñez-O’Mara, A., Nistal, M., Ortega, S., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5871 · Cited by 27
The homeobox gene DLX4 promotes generation of human induced pluripotent stem cells
Tamaoki, N., Takahashi, K., Aoki, H., Iida, K., Kawaguchi, T., Hatakeyama, D., Inden, M., Chosa, N., Ishisaki, A., Kunisada, T., et al. (2014) · Scientific Reports · doi:10.1038/srep07283 · Cited by 29
Sobol, M., Raykova, D., Cavelier, L. B., Khalfallah, A., Schuster, J., & Dahl, N. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0061 · Cited by 29
Clinical Grade iPS Cells: Need for Versatile Small Molecules and Optimal Cell Sources
Wu, Y., Pandian, G. N., Ding, Y., Zhang, W., Tanaka, Y., & Sugiyama, H. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.016 · Cited by 27
Cell-Cycle Regulation in Embryonic Stem Cells: Centrosomal Decisions on Self-Renewal
Koledova, Z. S., Krämer, A., Kafkova, L. R., & Divoký, V. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0136 · Cited by 29
“Further, loss of p53 may facilitate the reprogramming by promoting immortalization [63,70].”
Human Fibroblast Reprogramming to Pluripotent Stem Cells Regulated by the miR19a/b-PTEN Axis
He, X., Cao, Y., Wang, L., Han, Y., Zhong, X., Zhou, G., Cai, Y., Zhang, H., & Gao, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095213 · Cited by 27
Generation of Induced Pluripotent Stem Cells from Somatic Cells
Sohn, Y.-D., Han, J. W., & Yoon, Y. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398459-3.00001-0 · Cited by 33
Transduction of Cell-Penetrating Peptides into Induced Pluripotent Stem Cells
Yukawa, H., Noguchi, H., Nakase, I., Miyamoto, Y., Oishi, K., Hamajima, N., Futaki, S., & Hayashi, S. (2010) · Cell Transplantation · doi:10.3727/096368910x509031 · Cited by 26
Will Cell Reprogramming Resolve the Embryonic Stem Cell Controversy? A Narrative Review
Power, C. A., & Rasko, J. E. J. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-2-201107190-00007 · Cited by 30
“Second, human iPS cells have been differentiated into trophoblastic cells (76).”
BackgroundRim, Y. A., Nam, Y., & Ju, J. H. (2018) · Cell Transplantation · doi:10.1177/0963689718794864 · Cited by 25
An Efficient Protocol for Single-Cell Cloning Human Pluripotent Stem Cells
Singh, A. M. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00011 · Cited by 23
“Although, we have not tested human cells for feeders, previous reports have suggested that human fibroblasts provide superior feeder layers to MEFs (Cobo et al., 2008; Mali et al., 2008).”
ResultActivin/Nodal Signaling Switches the Terminal Fate of Human Embryonic Stem Cell-derived Trophoblasts
Sarkar, P., Randall, S. M., Collier, T. S., Nero, A., Russell, T. A., Muddiman, D. C., & Rao, B. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620641 · Cited by 25
Application of induced pluripotent stem cells to hematologic disease
Kim, P. G., & Daley, G. Q. (2009) · Cytotherapy · doi:10.3109/14653240903348319 · Cited by 24
Baharvand, H., Totonchi, M., Taei, A., Seifinejad, A., Aghdami, N., & Salekdeh, G. H. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-369-5_23 · Cited by 25
Review: Trophoblast differentiation from human embryonic stem cells
Golos, T. G., Giakoumopoulos, M., & Gerami‐Naini, B. (2012) · Placenta · doi:10.1016/j.placenta.2012.11.019 · Cited by 23
“Our understanding of the significance of hESC and iPSC differentiation [33] will be enhanced by better definition of the potential heterogeneity of trophoblast populations which arise from hESC differentiation paradigms.”
Song, M., Paul, S., Lim, H., Dayem, A. A., & Cho, S. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0205-9 · Cited by 23
“, 2010) Shwachman-Bodian-Diamond syndrome (SBDS) ND No (Mali et al., 2008; Park et al., 2008a; Somers et al., 2010) Alzheimer’s disease (AD) Neurons γ-secretase inhibitors and modulators (Compound W) (Yagi et al.”
BackgroundDisease Models from Pluripotent Stem Cells
Lengerke, C., & Daley, G. Q. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04962.x · Cited by 27
Stem cells: The promises and perils of p53
Krizhanovsky, V., & Lowe, S. W. (2009) · Nature · doi:10.1038/nature08367 · Cited by 21
Yan, Y. C., Yin, P., Gong, H., Xue, Y., Zhang, G., Fang, B., Chen, Z., Li, Y., Yang, C., Huang, Z., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000438634 · Cited by 21
Takahashi, K. (2010) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2010.01169.x · Cited by 21
“greatly improved the reprogramming frequency of human fibroblasts (Mali et al. 2008).”
BackgroundGalat, V., Malchenko, S., Galat, Y., Ishkin, A., Nikolsky, Y., Kosak, S. T., Soares, B. M., Iannaccone, P. M., Crispino, J. D., & Hendrix, M. J. C. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0578 · Cited by 19
Gong, H., Yan, Y. C., Fang, B., Xue, Y., Yin, P., Li, L., Zhang, G., Sun, X., Chen, Z., Ma, H., et al. (2014) · Stem Cells · doi:10.1002/stem.1702 · Cited by 19
Current status and future prospects of patient-derived induced pluripotent stem cells
Wang, Z., Zheng, J., Pan, R., & Chen, Y. (2021) · Human Cell · doi:10.1007/s13577-021-00592-2 · Cited by 20
Chae, S. A., Son, J. S., Zhao, L., Gao, Y., Liu, X., de Avila, J. M., Zhu, M. J., & Du, . (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00023.2022 · Cited by 17
Strategies to Generate Induced Pluripotent Stem Cells
Hayes, M., & Zavazava, N. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-478-4_6 · Cited by 19
Technological Progress in Generation of Induced Pluripotent Stem Cells for Clinical Applications
Oh, S.-I., Lee, C. K., Cho, K. J., Lee, K.-O., Cho, S., & Hong, S. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/417809 · Cited by 27
“Park et al. increased reprogramming efficiency approximately 3- fold using SV40 large antigen (SV40LT) and human telomerase reverse transcriptase (hTERT) as additional factors in combination with Oct, Sox2, Klf4, and c-Myc (OSKM) [74, 75].”
BackgroundGolos, T. G., Giakoumopoulos, M., & Garthwaite, M. A. (2010) · Reproduction · doi:10.1530/rep-09-0544 · Cited by 18
Comerford, S. A., Schultz, N. D., Hinnant, E. A., Klapproth, S., & Hammer, R. E. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.27 · Cited by 18
Promise and challenges of human iPSC-based hematologic disease modeling and treatment
Ye, Z., Chou, B.-K., & Cheng, L. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1095-9 · Cited by 20
“reprogramming factors [2, 3, 5, 6].”
Self-citationIntegrase deficient lentiviral vector: prospects for safe clinical applications
Yew, C.-H. T., Gurumoorthy, N., Nordin, F., Tye, G. J., Zaman, W. S. W. K., Tan, J. J., & Ng, M. H. (2022) · PeerJ · doi:10.7717/peerj.13704 · Cited by 21
“While retroviral transduction was used by Yamanaka to reprogram the cells, Mali et al. (2008) has successfully reprogrammed human fibroblast to a pluripotent state that resembles human embryonic stem (hES) cells by IDLV transduction of the original Yamanaka’s factors with the addition of SV40 Tag.”
BackgroundInfluentialPetkov, S., Hyttel, P., & Niemann, H. (2013) · Cellular Reprogramming · doi:10.1089/cell.2012.0053 · Cited by 17
Reprogramming of Human Huntington Fibroblasts Using mRNA
Arnold, A., Naaldijk, Y., Fabian, C., Loeffler‐Wirth, H., Binder, H., Nikkhah, G., Armstrong, L., & Stolzing, A. (2011) · ISRN Cell Biology · doi:10.5402/2012/124878 · Cited by 18
“[40], and Nanog, as described by Yu et al.”
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
Bailly, A., Milhavet, O., & Lemaître, J.-M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020317 · Cited by 19
“viruses (NILVs, defective in integrase activity) but with a 50-fold lower efficiency than their integrating counterpart [56].”
BackgroundMolecular mechanisms of pluripotency and reprogramming
Na, J., Plews, J. R., Li, J., Wongtrakoongate, P., Tuuri, T., Féki, A., Andrews, P. W., & Unger, C. A. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt33 · Cited by 21
Rehman, A., Fatima, I., Noor, F., Qasim, M., Wang, P., jia, J., Alshabrmi, F. M., & Liao, M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108661 · Cited by 19
Induced Pluripotent Stem Cells
Yu, J., & Thomson, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00030-6 · Cited by 23
Recurrent trisomy and Robertsonian translocation of chromosome 14 in murine iPS cell lines
Chen, Q., Shi, X., Rudolph, C., Yu, Y., Zhang, D., Zhao, X., Mai, S., Wang, G., Schlegelberger, B., & Shi, Q. (2011) · Chromosome Research · doi:10.1007/s10577-011-9239-y · Cited by 16
“that cells with an abnormal karyotype progressively increased with cell passaging in human iPS (Mali et al. 2008) and ES (Draper et al.”
BackgroundAn Improved Method for Generating and Identifying Human Induced Pluripotent Stem Cells
Mali, P., Ye, Z., Chou, B.-K., Yen, J. S., & Cheng, L. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-691-7_12 · Cited by 16
Self-citationStem Cells and Somatic Cells: Reprogramming and Plasticity
Estrov, Z. E. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.s.031 · Cited by 21
Differentiation of human-induced pluripotent stem cells into insulin-producing clusters.
Shaer, A., Azarpira, N., Vahdati, A., Karimi, M. H., & Shariati, M. (2014) · Experimental and Clinical Transplantation · doi:10.6002/ect.2013.0131 · Cited by 15
Goyal, A., Chavez, S. L., & Pera, R. A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082838 · Cited by 14
Establishment of mouse intestinal myofibroblast cell lines
Kawasaki, H., Ohama, T., Hori, M., & Sato, K. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i17.2629 · Cited by 15
Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia
Reis, L. C. J., Picanço‐Castro, V., Paes, B. C. M. F., Pereira, O. A., Gyuricza, I. G., de Araújo, F. T., Morato-Marques, M., Moreira, L. F., Costa, E. D. B. O., dos Santos, T. P. M., et al. (2017) · Stem Cells International · doi:10.1155/2017/7492914 · Cited by 14
“The stimulation of Tg in reprogramming was observed by other groups using different vectors and cell types [46, 47].”
BackgroundJerebtsova, M., Kumari, N., Xu, M., de Melo, G. E. B. A., Niu, X., Jeang, K., & Nekhai, S. A. (2012) · Biology · doi:10.3390/biology1020175 · Cited by 14
“Recently it was demonstrated that the presence of SV40 large T antigen increases the efficiency of iPSC production by 20 70 folds and reduces the number of required factors from four to two, Oct-4 and Sox2 [12].”
BackgroundInfluentialOka, Y., Nakajima, K., Nagao, K., Miura, K., Ishii, N., & Kobayashi, H. (2010) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0603008 · Cited by 15
Potential of Human Induced Pluripotent Stem Cells Derived from Blood and Other Postnatal Cell Types
Ye, Z., & Cheng, L. (2010) · Regenerative Medicine · doi:10.2217/rme.10.38 · Cited by 14
Self-citationLiu, M., Zhao, L., Wang, Z., Su, H. L., Wang, T., Yang, G., Chen, L., Wu, B., Zhao, G., Guo, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.785055 · Cited by 15
“Also, SV40 large T antigen and human TERT markedly improved human and mouse iPSC reprogramming in efficiency and quality (Mali et al., 2008; Park et al., 2008).”
BackgroundThe iPS Technique Provides Hope for Parkinson’s Disease Treatment
Xu, L., Tan, Y., Ding, J., & Chen, S. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9145-2 · Cited by 14
“Mali [16] added SV40 large T antigen during the reprogramming course to enhance the efficiency by 23–70-fold from both human adult and fetal fibroblasts and shorten the time by 1-2 weeks.”
BackgroundMicroRNA‐mediated somatic cell reprogramming
Kuo, C., & Ying, S. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24385 · Cited by 13
“Even the addition of SV40 alone with Oct4, Sox2, Nanog, and Lin28 dramatically increased the reprogramming efficiency, by up to 70-fold [Mali et al., 2008].”
BackgroundPluripotent Stem Cells in Research and Treatment of Hemoglobinopathies
Arora, N., & Daley, G. Q. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011841 · Cited by 15
“Two groups have reported the generation of human iPSC models of SCA (Mali et al. 2008; Sebastiano et al. 2011).”
BackgroundSchott, J. W., Hoffmann, D., Maetzig, T., Müller, F.-J., Steinemann, D., Zychlinski, D., Cantz, T., Baum, C., & Schambach, A. (2014) · Gene Therapy · doi:10.1038/gt.2014.69 · Cited by 12
Swelstad, B. B., & Kerr, C. L. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s8051 · Cited by 15
Mechanism and methods to induce pluripotency
Wang, P., & Na, J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1107-1 · Cited by 15
“For instance, adding SV40 large T into the reprogramming mix accelerated the speed of iPSC formation; however, many of the iPSCs gained chromosomal abnormality (Mali et al., 2008).”
BackgroundMalecki, M. (2013) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000138 · Cited by 11
“Moreover, some of the main obstacles for streamlining of the pluripotent stem cells into regenerative medicine, including the ethical constraints for using pluripotent embryonic stem cells, incompatibility of human pluripotency stem cells’ biomarkers with those of other species, controversies surrounding trans-differe…”
Neoplastic human embryonic stem cells as a model of radiation resistance of human cancer stem cells
Dingwall, S., Lee, J. B., Guezguez, B., Fiebig‐Comyn, A., McNicol, J. D., Boreham, D. R., Collins, T. J., & Bhatia, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4165 · Cited by 13
“Further, the efficiency of induced pluripotent stem (iPS) cell reprogramming is improved by p53 interference using the SV40 large T antigen (Mali et al., 2008), or p53 small interfering RNAs (siRNAs) (Zhao”
BackgroundStrategies for future histocompatible stem cell therapy
Nehlin, J. O., & Barington, T. (2009) · Biogerontology · doi:10.1007/s10522-009-9213-7 · Cited by 11
“Interestingly, the addition of SV40 large T to both sets of four reprogramming factors (Takahashi et al. 2007a; Yu et al. 2007a) has led to 23–70 fold efficiency in generating iPS cells from human postnatal fibroblasts (Mali et al. 2008).”
BackgroundBen‐Yehudah, A., Easley, C. A., Hermann, B. P., Castro, C. A., Simerly, C. R., Orwig, K. E., Mitalipov, S. M., & Schatten, G. P. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt24 · Cited by 12
New windows to enhance direct reprogramming of somatic cells towards induced pluripotent stem cells
Nakhaei‐Rad, S., Bahrami, A. R., Mirahmadi, M., & Matin, M. M. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-064 · Cited by 9
Parameswaran, S., Balasubramanian, S., Rao, M. S., & Ahmad, I. (2011) · Stem Cells · doi:10.1002/stem.655 · Cited by 12
iPS cells generation: an overview of techniques and methods
Telpalo-Carpio, S. A., Aguilar‐Yáñez, J. M., González‐Garza, M. T., Cruz-Vega, D., & Moreno-Cuevas, J. E. (2013) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0901002 · Cited by 10
“Different combinations that include also Nanog homebox [3, 9, , Stat3 ([3]), LIN28 [18, , Esrrb ([20]), SV40LT ([21-23]), UTF-1 , p53 siRNA([24]), hTERT ([23]), Wnt3a [26] and Nr5a2 [27] had been used as well, some of which have proved to increase reprogramming efficiency or are able to substitute one of the OSKM gene…”
BackgroundInfluentialGenomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming
Kanawaty, A., & Henderson, J. T. (2009) · Bioessays · doi:10.1002/bies.200800204 · Cited by 11
Investigating cellular identity and manipulating cell fate using induced pluripotent stem cells
Sugawara, T., Nishino, K., Umezawa, A., & Akutsu, H. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt99 · Cited by 17
From embryonic stem cells to iPS – an ethical perspective
Suaudeau, J. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2010.00723.x · Cited by 10
Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent Cells
Shi, H., Fu, Q., Li, G., Ren, Y., Hu, S., Ni, W., Guo, F., Shi, M., Meng, L., Zhang, H., et al. (2015) · Cellular Reprogramming · doi:10.1089/cell.2015.0039 · Cited by 9
“In recent years, iPSCs have been generated with varied efficiency from multiple cell types, including adult or fetal fibroblasts (Mali et al., 2008), adipose tissue–derived cells (Sugii et al., 2010; Sun et al., 2009; Tat et al., 2010), renal epithelial cells (Zhou et al., 2012), keratinocytes…”
BackgroundThongararm, P., Fedeles, B. I., Khumsubdee, S., Armijo, A. L., Kim, L., Thiantanawat, A., Promvijit, J., Navasumrit, P., Ruchirawat, M., Croy, R. G., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00444 · Cited by 8
Wang, L., Zhu, H., Wu, J., Li, N., & Hua, J. (2013) · Cytotechnology · doi:10.1007/s10616-013-9639-2 · Cited by 8
“HEK293T cells have been transducted with SV40 large T antigen (T), which has been reported to enhance the efficiency of generating iPS cells by 23–70 fold from both human adult and fetal fibroblasts (Mali et al. 2008).”
BackgroundTrophoblast differentiation of human embryonic stem cells
Tiruthani, K., Sarkar, P., & Rao, B. M. (2013) · Biotechnology Journal · doi:10.1002/biot.201200203 · Cited by 8
“Along similar lines, differentiation of iPSC to trophoblastlike cells using EBs has also been reported [52].”
Looking into the Black Box: Insights into the Mechanisms of Somatic Cell Reprogramming
David, L., Samavarchi‐Tehrani, P., Golipour, A., & Wrana, J. L. (2011) · Genes · doi:10.3390/genes2010081 · Cited by 9
“senescence hinders reprogramming [18,19].”
Shaw, A., Joseph, G. L., Jasti, A. C., Sastry, L., Witting, S. R., & Cornetta, K. G. (2016) · Gene Therapy · doi:10.1038/gt.2016.69 · Cited by 11
TET2 Haploinsufficiency Alters Reprogramming into Induced Pluripotent Stem Cells
Secardin, L., Limia, C. E. G., Stefano, A. D., Bonamino, M., Saliba, J., Kataoka, K., Rehen, S. K., Raslová, H., Marty, C., Ogawa, S., et al. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101755 · Cited by 8
Induced pluripotent stem cells
Shevchenko, A. I., Medvedev, S. P., Mazurok, N. A., & Zakian, S. M. (2009) · Russian Journal of Genetics · doi:10.1134/s1022795409020021 · Cited by 8
“In addition, iPSs were obtained with adenoviruses, which are normally not integrated in the genome [48], and lentiviruses that carried a mutation of the gene responsible for integration [26].”
The Art of Human Induced Pluripotent Stem Cells: The Past, the Present and the Future
Zhang, X., Angeles, A. D. L., & Zhang, J. (2010) · The Open Stem Cell Journal · doi:10.2174/1876893801002010002 · Cited by 11
Murakami, T., Saitoh, I., Inada, E., Kurosawa, M., Iwase, Y., Noguchi, H., Terao, Y., Yamasaki, Y., Hayasaki, H., & Sato, M. (2013) · Cell Medicine · doi:10.3727/215517913x674234 · Cited by 7
Eun, K., Hwang, S., Jeong, Y. W., Seo, S., Lee, S. Y., Hwang, W. S., Hyun, S., & Kim, H. (2017) · Biological Procedures Online · doi:10.1186/s12575-017-0061-6 · Cited by 8
“Additionally, numerous studies suggested that ectopic expression of SV40LT enhances induced pluripotent stem cell generation efficiency or even replaces Klf4 and c-Myc among four Yamanaka reprograming factors [15, 16].”
Chromosomal instability of mouse pluripotent cells cultured in vitro
Minina, Y. M., Жданова, Н. С., Shilov, A. G., Tolkunova, E. N., Liskovykh, M. A., & Tomilin, A. N. (2010) · Cell and Tissue Biology · doi:10.1134/s1990519x10030016 · Cited by 7
“It should be noted that generated human iPS cell lines have both normal (Park et al., 2008) and rearranged karyotypes (Mali et al., 2008).”
BackgroundWang, L., Zhu, M., Guo, Q., Fan, X., Lu, Y., Zhu, S., Wang, Y., Huang, Y. H., & Wang, Z. (2012) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-012-9493-0 · Cited by 7
Dolatshad, H., Tatwavedi, D., Ahmed, D., Tegethoff, J. F., Boultwood, J., & Pellagatti, A. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.10.001 · Cited by 11
Metadata
- Authors
- Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Cheng, Linzhao
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-29
- Volume
- 26
- Issue
- 8
- Pages
- 1998-2005
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2061824613
- Cited by
- 291
- References
- 32
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 9 · 2016: 14 · 2015: 19 · 2014: 19 · 2013: 20 · 2012: 30
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl073781-10)
- National Heart, Lung, and Blood Institute (R01 HL-073781)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, fibroblast reprogramming, SV40 large T antigen, reprogramming efficiency, human embryonic stem cells, teratoma formation, embryoid body differentiation, trophoblast differentiation, sickle cell disease, stem cell markers
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Differentiation, Cell Line, Culture Media, Fibroblasts, Homozygote, Humans, Karyotyping, Mutation, Lentivirus, Transgenes, Pluripotent Stem Cells, Embryo Culture Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.